Kornitzer Capital Management’s Krystal Biotech KRYS Stock Holding History

Kornitzer Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.88M	Buy	+13,126	New	+$3.92M	0.1%	196

Other funds holding KRYS

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Kornitzer Capital Management's KRYS Position: Q2 2026 in Review

Kornitzer Capital Management opened a new position in Krystal Biotech (KRYS) in Q2 2026: 13,126 shares worth $4.88M. The stake represents 0.1% of the portfolio and ranks #196 among its holdings.

117 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Kornitzer Capital Management held 13,126 shares of Krystal Biotech worth $4.88M as of Q2 2026.
Krystal Biotech was a new Kornitzer Capital Management position in Q2 2026.
Krystal Biotech made up 0.1% of Kornitzer Capital Management's portfolio in Q2 2026, its #196 holding.
117 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.